Market Place
Sourcing Support
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29
20 Oct 2023 //
GLOBENEWSWIRE
Zydus Lifesciences gets USFDA nod for generic acne-treating drug
20 Jun 2023 //
ECONOMIC TIMES
Zydus` Generic Minocycline Hydrochloride Receives Approval in the U.S.
16 Jun 2023 //
FDA
Journey Medical Announces Positive Data from PI Trial Assessing Impact of DFD-29
13 Jun 2023 //
GLOBENEWSWIRE
Nexus`s Generic Minocycline Hydrochloride Receives Approval in the U.S.
02 Jun 2023 //
FDA
New Clinical Study Suggests the Use of OraPharma’s ARESTIN Microspheres
18 May 2023 //
PRESS RELEASE
Journey Medical completes subject enrolment in PPR therapy trial
11 Jan 2023 //
CLINICALTRIALSARENA
Journey Medical Completes Enrollment in PIII Clinical Trials Evaluating DFD-29
10 Jan 2023 //
GLOBENEWSWIRE
Sidmak`s Generic Minocycline Hydrochloride Receives Approval in the U.S.
07 Oct 2022 //
FDA
Journey Medical Corporation Announces 50% Enrollment Milestone Achieved Phase 3
30 Aug 2022 //
GLOBENEWSWIRE
Nexus Pharma Generic Minocycline Hydrochloride Receives Approval in the U.S.
22 Jul 2022 //
FDA
Glenmark launches topical gel for treatment of moderate-severe acne
11 Jul 2022 //
ET HEALTH
VYNE Announces its China Partner’s Enrollment of First Patient in Ph3 AMZEEQ®
05 Oct 2021 //
GLOBENEWSWIRE
VYNE Therapeutics Announces Contract Execution for AMZEEQ® (minocycline)
21 Jan 2021 //
GLOBENEWSWIRE
VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ®
15 Dec 2020 //
GLOBENEWSWIRE
VYNE Announces Publication of Long-term Safety & Efficacy Data for ZILXI™
01 Dec 2020 //
GLOBENEWSWIRE
Citius Pharma Achieves Chemical Manufacturing & Control Milestones for Mino-Lok®
22 Sep 2020 //
PRNEWSWIRE
Therapeutic International Reports Synergistic Suppression of Suicide-Associated
28 Aug 2020 //
PRNEWSWIRE
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam
29 May 2020 //
PRNEWSWIRE
Menlo Therapeutics Announces Covered Status for AMZEEQ®
27 May 2020 //
GLOBENEWSWIRE
Aurobindo Pharma`s Generic Minocycline Hydrochloride Receives Approval in US
06 May 2020 //
FDA
Adamis Pharmaceuticals Announces Publication Demonstrating PET Scan Results
23 Apr 2020 //
GLOBENEWSWIRE
Menlo & Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™
23 Apr 2020 //
GLOBENEWSWIRE
Foamix Announces AMZEEQâ„¢ (minocycline) Achievement of Preferred Status P
14 Jan 2020 //
PR NEWSWIRE
Alkem Laboratories`s Generic Minocycline HCL Receives Approval in US
20 Dec 2019 //
FDA
Foamix Enters Contract Manufacturing Agreement
23 Oct 2019 //
CONTRACT PHARMA
Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline
18 Oct 2019 //
PR NEWSWIRE
Foamix Announces FDA Acceptance of its NDA for FMX103 Minocycline
17 Oct 2019 //
PR NEWSWIRE
Enforcement Report - Week of October 2, 2019
02 Oct 2019 //
FDA
Hovione Announces Phase 3 Program for Minocycline Meeting the FDA & Outlines
23 Sep 2019 //
PR NEWSWIRE
Aurobindo Pharma`s Generic Minocycline hydrochloride Receives Approval in US
22 Aug 2019 //
FDA
Mylan Labs` Generic Minocycline hydrochloride Receives Approval in US
22 Aug 2019 //
FDA
Mylan Labs` Generic Minocycline hydrochloride Receives Approval in US
02 Aug 2019 //
FDA
Zydus Cadila`s acne drug receives USFDA go-ahead
02 Aug 2019 //
ECONOMICTIMES
NHS England scraps 7 more drugs on prescription
09 Jul 2019 //
PHARMATIMES
Mylan`s Generic Minocycline Hydrochloride Receives Tentative Approval in US
23 Apr 2019 //
FDA
Foamix`s treatment for common skin condition meets late-stage trial goals
08 Nov 2018 //
REUTERS
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea
11 Oct 2018 //
PR NEWSWIRE
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea
11 Oct 2018 //
PR NEWSWIRE
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea
11 Oct 2018 //
PR NEWSWIRE
Aurobindo Pharma`s Generic Minocycline Hydrochloride Receives Approval in US
02 Oct 2018 //
FDA
Melinta Therapeutics Announces Closing of Underwritten Public Offering
29 May 2018 //
PRESS RELEASE
U.S. PTO Awards BioPharmX Patent Protection for Novel Tetracycline-class Drugs
20 Mar 2018 //
PRNEWSWIRE
Alkem Labs Generic Minocycline Hydrochloride Receives Approval In US
19 Mar 2018 //
FDA
Impax broke U.S. antitrust law by delaying generic drug, jury told
13 Mar 2018 //
REUTERS
Melinta to Highlight Commitment to Antibiotics and Product Portfolio
08 Mar 2018 //
PRESS RELEASE
Impax Announces the Launch of an Authorized Generic Version of Solodyn®
20 Feb 2018 //
PR NEWSWIRE
Melinta Completes Acquisition of The Medicines Company’s
08 Jan 2018 //
PRESS RELEASE
Zydus Cadila`s acne drug receives USFDA go-ahead
24 Nov 2017 //
Zydus Pharms USA’s Generic Minocycline HCL Receives Approval In US
17 Nov 2017 //
FDA
Acne antibiotic delays development of multiple sclerosis in small trial
01 Jun 2017 //
REUTERS
Foamix`s acne drug misses main goal in key study, shares slump
27 Mar 2017 //
REUTERS
BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01
12 Jan 2017 //
PR NEWSWIRE
BioPharmX Announces Full Patient Enrollment in Phase 2a Study of BPX-01 Topical Antibiotic for Acne
25 Apr 2016 //
PR NEWSWIRE
BioPharmX Announces Full Patient Enrollment in Phase 2a Study of BPX-01
25 Apr 2016 //
PR NEWSWIRE
US FDA Enforcement report- 13/Apr/2016
12 Apr 2016 //
FDA
